TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+13.24%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$482M
AUM Growth
+$482M
(+2.4%)
Cap. Flow
-$33.3M
Cap. Flow
% of AUM
-6.92%
Top 10 Holdings %
Top 10 Hldgs %
50.55%
Holding
78
New
26
Increased
9
Reduced
18
Closed
10
Top Buys
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$24.6M |
| 2 |
CVS Health
CVS
|
$16.9M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$10.7M |
| 4 |
Bioventus
BVS
|
$10.3M |
| 5 |
Henry Schein
HSIC
|
$7.62M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
$15.3M |
| 2 |
Perrigo
PRGO
|
$14.2M |
| 3 |
United Therapeutics
UTHR
|
$13.9M |
| 4 |
Pacira BioSciences
PCRX
|
$13M |
| 5 |
AtriCure
ATRC
|
$10.9M |
Sector Composition
| 1 | Healthcare | 86.27% |
| 2 | Consumer Staples | 4.33% |
| 3 | Technology | 4.31% |
| 4 | Consumer Discretionary | 0.47% |
| 5 | Industrials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSON
26
DELISTED
Misonix Inc
MSON
| $6.86M | 1.41% |
350,000
+50,000
| +17% | +$980K |
|
|
MSACU
27
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
| $5.91M | 1.21% |
+600,000
| New | +$5.91M |
|
28
HCA Healthcare
HCA
$95.4B
| $5.65M | 1.16% |
+30,000
| New | +$5.65M |
|
29
Vertex Pharmaceuticals
VRTX
$102B
| $5.37M | 1.1% |
25,000
-17,000
| -40% | -$3.65M |
|
30
Talkspace
TALK
$444M
| $4.96M | 1.02% |
+500,000
| New | +$4.96M |
|
31
InMode
INMD
$917M
| $4.55M | 0.93% |
62,850
-27,150
| -30% | -$1.96M |
|
|
DMTK
32
DELISTED
DermTech, Inc. Common Stock
DMTK
| $4.27M | 0.88% |
84,000
+59,000
| +236% | +$3M |
|
33
UnitedHealth
UNH
$279B
| $3.72M | 0.76% |
+10,000
| New | +$3.72M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.55M | 0.73% |
575,000
-275,000
| -32% | -$1.7M |
|
35
Viatris
VTRS
$12.3B
| $3.49M | 0.72% |
250,000
-200,000
| -44% | -$2.79M |
|
36
Evolent Health
EVH
$1.11B
| $2.53M | 0.52% |
+125,000
| New | +$2.53M |
|
37
Topgolf Callaway Brands
MODG
$1.69B
| $2.17M | 0.44% |
+81,000
| New | +$2.17M |
|
38
Xeris Biopharma Holdings
XERS
$1.27B
| $1.58M | 0.32% |
+350,000
| New | +$1.58M |
|
|
CMIIU
39
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| $1.28M | 0.26% |
+100,000
| New | +$1.28M |
|
|
40
Perrigo
PRGO
$3.21B
| $1.01M | 0.21% |
25,000
-350,000
| -93% | -$14.2M |
|
41
Cerus
CERS
$251M
| $902K | 0.19% |
+150,000
| New | +$902K |
|
|
OPTN
42
DELISTED
OptiNose
OPTN
| $646K | 0.13% |
175,000
-1,797,000
| -91% | -$6.63M |
|
|
AAT
43
American Assets Trust
AAT
$1.28B
| $389K | 0.08% |
+12,000
| New | +$389K |
|
44
Northrop Grumman
NOC
$83.2B
| $388K | 0.08% |
+1,200
| New | +$388K |
|
45
Calix
CALX
$3.83B
| $347K | 0.07% |
+10,000
| New | +$347K |
|
46
Cameco
CCJ
$33.6B
| $332K | 0.07% |
+20,000
| New | +$332K |
|
47
Sonos
SONO
$1.7B
| $262K | 0.05% |
+7,000
| New | +$262K |
|
48
First Solar
FSLR
$21.6B
| $218K | 0.04% |
+2,500
| New | +$218K |
|
49
Ryerson Holding
RYI
$722M
| $170K | 0.03% |
+10,000
| New | +$170K |
|
|
HMHC
50
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $152K | 0.03% |
+20,000
| New | +$152K |
|